Cresp is the world's first generic version of darbepoetin alpha in the world and the only darbepoetin alfa in India. Darbepoetin alfa is a modified version of epoetin alfa, which is engineered to have a longer half life, increasing (up to 3 times) the time it remains in the blood. This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anaemia with epoetin which is the current standard of care in India.
Or contact the seller
in section "Injectable Products"